Synaptotagmin-like protein 5 (Slp5) belongs to the synaptotagmin family, which is known for its involvement in the regulation of membrane trafficking and neurotransmitter release. Members of this family typically contain C2 domains that bind to calcium and phospholipids, which are key in their role in vesicle trafficking and exocytosis.As a "like" member of the synaptotagmin family, Slp5 shares homology with classical synaptotagmins but can have distinct functions or regulatory mechanisms. These proteins are often involved in the fine-tuning of vesicle-mediated transport and membrane fusion events, which are critical for processes such as synaptic transmission, hormone release, and other cellular secretion mechanisms.
The specific function of Slp5 can vary by cell type and organism. In general, synaptotagmin-like proteins are thought to help coordinate the docking and release of vesicles in response to increases in intracellular calcium levels, a crucial step in ensuring rapid and precise signal transmission across synapses or release of substances from a cell. These proteins can interact with SNARE proteins and other components of the vesicle fusion machinery, modulating their function in a calcium-dependent manner.Mutations or dysregulation of synaptotagmin-like proteins, including Slp5, could potentially lead to various neurological disorders or contribute to the pathology of metabolic diseases, as vesicle trafficking is critical in many signaling pathways and cellular processes.
VEJA TAMBÉM
Items 1 to 10 of 11 total
Mostrar:
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
O PMA ativa a proteína quinase C (PKC), que pode influenciar a exocitose das vesículas sinápticas, afectando potencialmente as vias relacionadas com o SYTL5. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
A forskolina ativa a adenilato ciclase, aumentando os níveis de AMPc, o que pode modular indiretamente a atividade do SYTL5 através de vias dependentes da PKA. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Este composto perturba o aparelho de Golgi e pode afetar o tráfico de proteínas como a SYTL5. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
O nocodazol perturba os microtúbulos e pode influenciar o tráfico intracelular, afectando potencialmente a função do SYTL5. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
A monensina é um ionóforo que perturba os gradientes iónicos intracelulares, afectando potencialmente o tráfico de vesículas relacionadas com o SYTL5. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A wortmannina, um inibidor da PI3K, pode afetar indiretamente o SYTL5 através da alteração das vias de sinalização intracelular. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Trata-se de outro inibidor da PI3K, que pode ter impacto nas vias de sinalização relacionadas com a atividade do SYTL5. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Como inibidor da mTOR, a rapamicina pode afetar vários processos celulares, influenciando potencialmente a função do SYTL5. | ||||||
Benzyl mercaptan | 100-53-8 | sc-353053 sc-353053A | 25 g 100 g | $41.00 $63.00 | ||
Embora seja um material biológico, o papel do NGF no desenvolvimento e função neural pode influenciar indiretamente o SYTL5. | ||||||
Bis(pinacolato)diboron | 73183-34-3 | sc-252467 sc-252467A | 1 g 5 g | $43.00 $80.00 | ||
À semelhança do NGF, o PDGF é um fator biológico que pode modular as vias de sinalização celular que afectam o SYTL5. | ||||||